Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Duffy

Showing results (951-960 of 1,071) with videos related to

Pageof 108
Sort By:
Histopathology|October 22, 2013
Investigation of molecular alterations of AKT-3 in triple-negative breast cancerGillian O'Hurley, Etáin Daly, Anthony O'Grady, et al.
Oncotarget|August 18, 2016
Wnt signalling is a bi-directional vulnerability of cancer cellsDavid J Duffy, Aleksandar Krstic, Thomas Schwarzl, et al.
The Review of Scientific Instruments|May 3, 2011
A comb-sampling method for enhanced mass analysis in linear electrostatic ion trapsJ B Greenwood, O Kelly, C R Calvert, et al.
The Journal of Clinical Investigation|December 22, 1999
Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heartE D Abel, H C Kaulbach, R Tian, et al.
The American Journal of Cardiology|October 29, 2024
Outcomes After Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass GraftingNaomi S Cohen, Andrew E Ajani, Diem Dinh, et al.
Breast Cancer Research and Treatment|November 3, 2012
Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumoursBrigid C Browne, Alex J Eustace, Susan Kennedy, et al.
American Heart Journal|April 21, 2009
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stentsMichelle J Butler, David Eccleston, David J Clark, et al.
American Heart Journal|November 15, 2021
Long-term mortality in asymptomatic patients with stable ischemic heart disease undergoing percutaneous coronary interventionAnoop N Koshy, Diem T Dinh, Jordan Fulcher, et al.
Oncotarget|September 7, 2013
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancerAlexandra Canonici, Merel Gijsen, Maeve Mullooly, et al.
The American Journal of Cardiology|July 23, 2019
Impact of Gender and Door-to-Balloon Times on Long-Term Mortality in Patients Presenting With ST-Elevation Myocardial InfarctionAlexandra C Murphy, Matias B Yudi, Omar Farouque, et al.
Pageof 108

Showing results (951-960 of 1,071) with videos related to

Sort By:
Pageof 108
Histopathology|October 22, 2013
Investigation of molecular alterations of AKT-3 in triple-negative breast cancerGillian O'Hurley, Etáin Daly, Anthony O'Grady, et al.
Oncotarget|August 18, 2016
Wnt signalling is a bi-directional vulnerability of cancer cellsDavid J Duffy, Aleksandar Krstic, Thomas Schwarzl, et al.
The Review of Scientific Instruments|May 3, 2011
A comb-sampling method for enhanced mass analysis in linear electrostatic ion trapsJ B Greenwood, O Kelly, C R Calvert, et al.
The Journal of Clinical Investigation|December 22, 1999
Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heartE D Abel, H C Kaulbach, R Tian, et al.
The American Journal of Cardiology|October 29, 2024
Outcomes After Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass GraftingNaomi S Cohen, Andrew E Ajani, Diem Dinh, et al.
Breast Cancer Research and Treatment|November 3, 2012
Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumoursBrigid C Browne, Alex J Eustace, Susan Kennedy, et al.
American Heart Journal|April 21, 2009
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stentsMichelle J Butler, David Eccleston, David J Clark, et al.
American Heart Journal|November 15, 2021
Long-term mortality in asymptomatic patients with stable ischemic heart disease undergoing percutaneous coronary interventionAnoop N Koshy, Diem T Dinh, Jordan Fulcher, et al.
Oncotarget|September 7, 2013
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancerAlexandra Canonici, Merel Gijsen, Maeve Mullooly, et al.
The American Journal of Cardiology|July 23, 2019
Impact of Gender and Door-to-Balloon Times on Long-Term Mortality in Patients Presenting With ST-Elevation Myocardial InfarctionAlexandra C Murphy, Matias B Yudi, Omar Farouque, et al.
Pageof 108